Inactive Instrument

News Pluristem Therapeutics Nasdaq

Equities

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 08	MT
Sector Update: Health Care	Apr. 08	MT
Pluri Receives US Patent for Immune Cell Expansion	Apr. 08	MT
Pluri Inc. Unveils A Novel Method for Expansion of Immune Cells Using Proprietary Technology	Apr. 08	CI
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method	Apr. 08	AQ
Reverse Split: 1 of 8	Mar. 31	FA
Pluri : Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences	Mar. 28	PU
Pluri Inc. Announces 1-for-8 Reverse Share Split	Mar. 27	AQ
Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report	Mar. 21	AQ
Pluri : Announced its participation in upcoming conferences,details	Mar. 19	PU
Engage with Pluri's Talent: Exciting Conference Appearances Ahead	Mar. 19	AQ
Pluri : Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturingor Announcement	Mar. 14	PU
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing	Mar. 14	AQ
Pluri Selected as Cdmo by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing	Mar. 14	CI
Pluri : Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation	Mar. 11	PU
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation	Mar. 11	AQ
Pluri Inc. Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation	Mar. 11	CI
Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board	Mar. 06	AQ
Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board	Mar. 06	CI
Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals	Feb. 28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pluristem Therapeutics Nasdaq

Equities

Summary

Filters